31 Mar
The FDA’s First Moves: THE ORIGINAL CASE FOR RANDOMIZED CONTROLLED TRIALS
The logic behind the RCT research design seems unassailable. Before the efficacy of a new drug is actually tested, it is only theoretical. Even the most promising results from laboratory experiments and animal studies cannot always be replicated in humans. Reliable testing must ensure that drug effects are observed in a representative sample of patients [...]